Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry
- PMID: 25341707
- DOI: 10.1016/j.jcin.2014.05.017
Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry
Abstract
Objectives: The aim of this study was to determine the incidence, predictors, and outcomes of recurrent stent thrombosis (rST).
Background: Patients who had an initial stent thrombosis (ST) develop may be at high risk of rST.
Methods: We analyzed a multicenter California registry of angiographic definite ST at 5 academic hospitals from 2005 to 2013. A detailed review of the angiogram and procedure was performed of patients with and without rST.
Results: Among 221 patients with a median follow-up of 3.3 years, definite or probable rST developed in 29, including 19 with angiographic definite rST. The cumulative hazard ratio (HR) of definite or probable rST was 16% at 1 year and 24% at 5 years, whereas the cumulative HR of angiographic definite rST was 11% at 1 year and 20% at 5 years. Despite similar angiographic results, patients who had rST develop had significantly greater peak creatine kinase at the time of initial ST (mean, 2,655 mg/dl vs. 1,654 mg/dl; p = 0.05) than those without rST. The 3-year rate of major adverse cardiovascular events was 50% for patients with rST compared with 22% for patients with a single ST (p = 0.01). After multivariable adjustment, independent predictors of definite/probable rST were age (HR: 1.4; 95 confidence interval [CI]: 1.1 to 1.8 per 10 years), bifurcation ST (HR: 4.4; 95% CI: 1.8 to 10.9), and proximal vessel diameter (HR: 1.8; 95% CI: 1.1 to 3.2 per millimeter).
Conclusions: rST represents an important cause of long-term morbidity and mortality after an initial ST. Bifurcation ST and a larger proximal reference vessel diameter are independently associated with an increased risk of rST.
Keywords: angiography; recurrent stent thrombosis; stent thrombosis.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Shifting the focus to recurrences: so good we can afford it or too bad we cannot avoid it?JACC Cardiovasc Interv. 2014 Oct;7(10):1114-6. doi: 10.1016/j.jcin.2014.07.006. JACC Cardiovasc Interv. 2014. PMID: 25341708 No abstract available.
Similar articles
-
Angiographic predictors of recurrent stent thrombosis (from the Outcome of PCI for stent-ThrombosIs MultIcentre STudy [OPTIMIST]).Am J Cardiol. 2010 Jun 15;105(12):1710-5. doi: 10.1016/j.amjcard.2010.01.347. Am J Cardiol. 2010. PMID: 20538119 Clinical Trial.
-
Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes.JACC Cardiovasc Interv. 2013 Jan;6(1):36-43. doi: 10.1016/j.jcin.2012.08.018. Epub 2012 Dec 19. JACC Cardiovasc Interv. 2013. PMID: 23266233
-
Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study.Catheter Cardiovasc Interv. 2017 Jan;89(1):26-35. doi: 10.1002/ccd.26409. Epub 2016 Jan 27. Catheter Cardiovasc Interv. 2017. PMID: 26813732
-
Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).JACC Cardiovasc Interv. 2014 Oct;7(10):1093-102. doi: 10.1016/j.jcin.2014.04.017. Epub 2014 Sep 17. JACC Cardiovasc Interv. 2014. PMID: 25240540
-
Late Incomplete stent apposition is associated with late/very late stent thrombosis: A meta-analysis.Catheter Cardiovasc Interv. 2018 Feb 15;91(3):365-375. doi: 10.1002/ccd.27102. Epub 2017 May 30. Catheter Cardiovasc Interv. 2018. PMID: 28557311 Review.
Cited by
-
Recurrent Stent Thrombosis: An Interventionalist's Nightmare.J Am Heart Assoc. 2021 May 4;10(9):e020728. doi: 10.1161/JAHA.121.020728. Epub 2021 Apr 17. J Am Heart Assoc. 2021. PMID: 33870700 Free PMC article. No abstract available.
-
Identifying the Incidence, Predictors, Outcomes, and Prevention of Stent Thrombosis (ST) in Post-percutaneous Coronary Revascularization Patients With Drug-Eluting Stents (DES): A Systematic Review.Cureus. 2023 Sep 13;15(9):e45150. doi: 10.7759/cureus.45150. eCollection 2023 Sep. Cureus. 2023. PMID: 37842458 Free PMC article. Review.
-
The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short.Cardiovasc Diagn Ther. 2018 Oct;8(5):630-646. doi: 10.21037/cdt.2018.10.01. Cardiovasc Diagn Ther. 2018. PMID: 30498687 Free PMC article. Review.
-
Risk Factors and Outcomes of Recurrent Drug-Eluting Stent Thrombosis: Insights From the REAL-ST Registry.J Am Heart Assoc. 2021 May 4;10(9):e018972. doi: 10.1161/JAHA.120.018972. Epub 2021 Apr 17. J Am Heart Assoc. 2021. PMID: 33870710 Free PMC article.
-
Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1).Ann Saudi Med. 2016 Jan-Feb;36(1):17-22. doi: 10.5144/0256-4947.2016.17. Ann Saudi Med. 2016. PMID: 26922683 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources